PIK3CD-AS2
gene geneOn this page
Summary
PIK3CD-AS2 (PIK3CD antisense RNA 2, HGNC:51334) is a long non-coding RNA gene on chromosome 1p36.22.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51334 |
| Approved symbol | PIK3CD-AS2 |
| Name | PIK3CD antisense RNA 2 |
| Location | 1p36.22 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000231789 |
| Ensembl biotype | lncRNA |
| Entrez | 101929074 |
| RNAcentral | URS00007E3AB7 — lncRNA, 958 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 lncRNA
ENST00000415330, ENST00000775830, ENST00000775831
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000415330 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003455420 | 9672405 | 9672719 |
| ENSE00003987853 | 9680712 | 9681135 |
| ENSE00004143074 | 9687335 | 9687604 |
Expression profiles
Bgee: expression breadth ubiquitous, 152 present calls, max score 85.10.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.4703 / max 59.4981, expressed in 1150 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 10228 | 4.7172 | 1070 |
| 10226 | 0.3566 | 241 |
| 10225 | 0.1921 | 90 |
| 10227 | 0.1259 | 52 |
| 10224 | 0.0786 | 17 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.10 | gold quality |
| sural nerve | UBERON:0015488 | 72.68 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 72.01 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.35 | gold quality |
| colonic epithelium | UBERON:0000397 | 69.73 | silver quality |
| left ovary | UBERON:0002119 | 69.69 | gold quality |
| bone marrow cell | CL:0002092 | 69.42 | silver quality |
| islet of Langerhans | UBERON:0000006 | 69.32 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 69.27 | gold quality |
| body of pancreas | UBERON:0001150 | 69.26 | gold quality |
| pancreas | UBERON:0001264 | 68.70 | gold quality |
| thyroid gland | UBERON:0002046 | 67.90 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 66.74 | gold quality |
| right ovary | UBERON:0002118 | 66.12 | gold quality |
| adenohypophysis | UBERON:0002196 | 66.04 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 65.10 | gold quality |
| lymph node | UBERON:0000029 | 64.72 | gold quality |
| ovary | UBERON:0000992 | 64.66 | gold quality |
| pituitary gland | UBERON:0000007 | 64.26 | gold quality |
| adrenal tissue | UBERON:0018303 | 63.68 | gold quality |
| ectocervix | UBERON:0012249 | 63.01 | gold quality |
| body of uterus | UBERON:0009853 | 62.84 | gold quality |
| minor salivary gland | UBERON:0001830 | 62.83 | gold quality |
| cortical plate | UBERON:0005343 | 62.83 | gold quality |
| metanephros cortex | UBERON:0010533 | 62.77 | gold quality |
| endocervix | UBERON:0000458 | 62.75 | gold quality |
| cortex of kidney | UBERON:0001225 | 62.32 | gold quality |
| gall bladder | UBERON:0002110 | 61.86 | gold quality |
| right adrenal gland | UBERON:0001233 | 61.25 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 61.22 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.07 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.